Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

Sponsor

Memorial Sloan Kettering Cancer Center (Other)

Overall Status

Completed

CT.gov ID

NCT01003600

Collaborator

Queens Cancer Center of Queens Hospital (Other)

177

Enrollment

Locations

Duration (Months)

88.5

Patients Per Site

1.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

We are doing this study to learn more about colon and rectal cancer survivors. We want to know if survivors want more information about life after cancer. Do cancer survivors want to know more about their own cancer? Do cancer survivors want to know about their treatment? Do cancer survivors want to know what health care they should get in the future? We want to know what information to give to cancer survivors when they finish treatment.

Condition or Disease	Intervention/Treatment	Phase
Colon Cancer Rectal Cancer	Behavioral: Questionnaire

Study Design

Study Type:

Observational

Actual Enrollment :

177 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Colorectal Cancer Survivors' Needs and Preferences for Survivorship Information

Study Start Date :

Oct 1, 2009

Actual Primary Completion Date :

Nov 1, 2014

Actual Study Completion Date :

Nov 1, 2014

Arms and Interventions

Arm	Intervention/Treatment
Questionnaire This study is a cross-sectional survey study to be administered to adults who completed treatment for nonmetastatic colorectal cancer at MSKCC or at Queens Cancer Center (QCC) at Queens Hospital between 6 months and 2 years ago and have no evidence of disease at the time of study enrollment.	Behavioral: Questionnaire The questionnaire will be administered by telephone and will take approximately 20-30 minutes. The questionnaire will elicit survivor responses along five domains: knowledge about diagnosis and treatment, knowledge about ongoing risks and recommended testing, history of health care utilization since the end of treatment, preferences for relevant information about these topics, and employment after the end of cancer treatment. Other Names: The questionnaire will be administered using a Computer Assisted Telephone Interview (CATI) system. The CATI form of the questionnaire enables the interviewer to read aloud from a script and enter responses into the computer in real-time, regardless of whether the interview is conducted on the phone or in person. The CATI form of the questionnaire enables the interviewer to read aloud from a script and enter responses into the computer in real-time, regardless of whether the interview is conducted on the phone or in person.

Arm

Intervention/Treatment

Questionnaire

This study is a cross-sectional survey study to be administered to adults who completed treatment for nonmetastatic colorectal cancer at MSKCC or at Queens Cancer Center (QCC) at Queens Hospital between 6 months and 2 years ago and have no evidence of disease at the time of study enrollment.

Behavioral: Questionnaire

The questionnaire will be administered by telephone and will take approximately 20-30 minutes. The questionnaire will elicit survivor responses along five domains: knowledge about diagnosis and treatment, knowledge about ongoing risks and recommended testing, history of health care utilization since the end of treatment, preferences for relevant information about these topics, and employment after the end of cancer treatment.

Other Names:

The questionnaire will be administered using a Computer Assisted Telephone Interview (CATI)

system. The CATI form of the questionnaire enables the interviewer to read aloud from a script and

enter responses into the computer in real-time, regardless of whether the interview is conducted on the

phone or in person. The CATI form of the questionnaire enables the interviewer to read aloud from a

script and enter responses into the computer in real-time, regardless of whether the interview is

conducted on the phone or in person.

Outcome Measures

Primary Outcome Measures

Assess colorectal cancer survivors' basic knowledge of their own cancer history, including date of diagnosis, stage, and treatments received. [6 months to 2 years after completion of treatment]

Secondary Outcome Measures

Assess survivors' knowledge of medical issues relevant to colorectal cancer survivors. [6 months to 2 years after completion of treatment]
Describe the types of health care providers that survivors have visited since completing treatment for colorectal cancer. [6 months to 2 years after completion of treatment]
Assess survivors' preferences for the content, format, and delivery of survivorship care plans. [6 months to 2 years after completion of treatment]
Assess whether survivors who had concerns about working after cancer treatment spoke with health care professionals about their concerns. [6 months to 2 years after completion of treatment]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

18 years of age or older at diagnosis
Diagnosed with first primary colorectal cancer (stage I-III)
Completed last treatment for colorectal cancer (surgery, chemotherapy, or radiation) at least 6 months and no more than 2 years before the date of study enrollment
Able to speak English, because questionnaire is only available in English
Able to provide informed consent
Received all treatment for colorectal cancer at MSKCC or QCC or, surgical treatment at an outside facility, and all other treatment (chemotherapy or radiation) at MSKCC or QCC

Exclusion Criteria:

Undergoing active treatment for colorectal cancer
Diagnosed with metastatic colorectal cancer
Prior history of colorectal or any other cancer (except non-melanoma skin cancer)
Diagnosed with new or recurrent colorectal or other cancer after the primary colorectal cancer diagnosis
Received a survivorship care plan from the treating institution